AMYLASE - SERUM

The AMYLASE - SERUM test measures the activity of amylase in a blood sample. Amylase is a digestive enzyme that helps break down starch and other carbohydrates. It is produced mainly by the pancreas and salivary glands, with smaller contributions from other tissues. A limited amount normally circulates in the blood and is removed partly through the kidneys.

Serum amylase testing is commonly used during the evaluation of sudden or severe abdominal pain, particularly when acute pancreatitis or another pancreatic condition is suspected. However, amylase is not specific to the pancreas. Doctors usually interpret it alongside serum lipase, clinical symptoms, examination findings and imaging studies. Lipase generally remains elevated longer and is considered more specific for acute pancreatitis.

Benefits of the Test

• Measures amylase enzyme activity in serum.
• Supports evaluation of suspected acute pancreatitis.
• Helps investigate pancreatic-duct obstruction or pancreatic injury.
• May provide information about salivary-gland disease.
• Can assist in evaluating persistent unexplained hyperamylasemia.
• Provides a rapid biochemical result that can be reviewed with lipase and imaging.

Why Doctors Recommend This Test

A doctor may request serum amylase when a patient has severe upper abdominal pain, pain radiating to the back, nausea, vomiting, abdominal tenderness, fever or other symptoms suggestive of acute pancreatic inflammation. Possible causes of pancreatitis include gallstones, alcohol use, high triglycerides, certain medicines, trauma and other medical conditions.

Amylase may also increase with pancreatic-duct obstruction, pancreatic pseudocyst, abdominal surgery, trauma or reduced kidney clearance. Non-pancreatic causes include salivary-gland inflammation or obstruction, intestinal injury, selected gynaecological conditions and macroamylasemia. Therefore, an elevated result does not independently prove pancreatitis.

Macroamylasemia is a usually benign condition in which amylase binds to a large blood protein and cannot be filtered efficiently by the kidneys. This can cause persistently elevated serum amylase without symptoms of pancreatic disease. Amylase isoenzyme testing, urine amylase or an amylase-to-creatinine clearance calculation may be considered when this condition is suspected.

Preparation Before Test

Fasting is not always required for serum amylase, although the doctor or laboratory may request several hours of fasting, particularly when other blood tests are collected simultaneously. Follow the instructions given for the specific test appointment. Water is generally permitted unless advised otherwise.

Tell the healthcare team about alcohol use, pregnancy, kidney or liver disease, recent abdominal procedures and all medicines or supplements. Some medicines can influence pancreatic enzymes. Do not stop prescribed medication without the treating doctor's instructions. A routine venous blood sample is required.

Normal Reporting Time

Serum amylase is a routine biochemistry test, and the result is commonly available on the same day or within 24 hours after the sample reaches the laboratory. Turnaround time may vary according to the collection time, transport, instrument availability, sample quality and laboratory workflow. Urgent hospital testing may be reported more quickly according to clinical arrangements.

Who Should Take This Test?

• Patients with sudden or severe upper abdominal pain.
• People with symptoms suggesting acute pancreatitis.
• Patients with suspected pancreatic-duct obstruction or pancreatic injury.
• Individuals being assessed after abdominal trauma or selected procedures.
• People with salivary-gland swelling or inflammation when amylase evaluation is relevant.
• Patients with persistent or unexplained elevation of pancreatic enzymes.
• Anyone specifically advised to take the test by a physician or gastroenterologist.

Detailed Information

In acute pancreatitis, serum amylase may rise within hours of symptom onset and can return toward normal within several days. A normal result obtained later in the illness does not necessarily exclude pancreatitis. Some patients with pancreatitis related to very high triglycerides or with chronic pancreatic damage may not show a marked amylase elevation.

The laboratory compares the result with its method-specific reference interval. Amylase levels several times above the upper reference limit may strengthen suspicion of acute pancreatitis when typical symptoms are present, but the result must not be interpreted without clinical context. The numerical level does not reliably indicate how severe the pancreatitis is.

Doctors commonly request serum lipase with or instead of amylase because lipase is more closely associated with pancreatic injury and generally remains elevated for a longer period. Additional tests may include a complete blood count, liver enzymes, bilirubin, kidney function, calcium, triglycerides, C-reactive protein and glucose. Ultrasound, CT or MRI may be needed to identify gallstones, inflammation, complications or another cause of abdominal pain.

Low amylase activity can occur with extensive chronic pancreatic damage, cystic fibrosis or certain other conditions, but a low result is not diagnostic by itself. Tests of pancreatic exocrine function, such as faecal elastase, and imaging may be more useful when chronic pancreatic insufficiency is suspected.

Patients with severe abdominal pain, persistent vomiting, fever, faintness or breathing difficulty require prompt medical assessment. The serum amylase result should always be reviewed by a healthcare professional who can interpret it with symptoms, examination findings and other investigations.